We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
Cap. Flow
-$8.07M
Cap. Flow %
-0.07%
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
18.2 quarters
Top 10 Avg Time Held
3.2 quarters
Top 20 Avg Time Held
7.1 quarters

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$43.3M
2
MSA icon
Mine Safety
MSA
+$37.1M
3
YSWY icon
Yesway Inc
YSWY
+$34.7M
4
DORM icon
Dorman Products
DORM
+$24.6M
5
AVTR icon
Avantor
AVTR
+$19M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$54.5M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$51.1M
3
MKSI icon
MKS Inc
MKSI
+$44.5M
4
VSH icon
Vishay Intertechnology
VSH
+$40.2M
5
LFUS icon
Littelfuse
LFUS
+$35.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.88%
2 Technology 19.45%
3 Financials 14.84%
4 Consumer Discretionary 12.86%
5 Healthcare 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
COTY icon
676
Coty
COTY
$2.56B
$1.08M 0.01%
+500,000
New +$1.08M
2026 Q2
0 quarters
GDYN icon
677
Grid Dynamics Holdings
GDYN
$636M
$1.08M 0.01%
189,550
-227,450
-55% -$1.41M
2025 Q4
2 quarters
NICE icon
678
Nice
NICE
$6.74B
$1.07M 0.01%
11,795
-2,995
-20% -$290K
2025 Q2
4 quarters
EXTR icon
679
Extreme Networks
EXTR
$3.11B
$1.05M 0.01%
32,402
+6,796
+27% +$164K
2021 Q4
18 quarters
INVX icon
680
Innovex International
INVX
$2B
$1.02M 0.01%
41,300
+22,305
+117% +$606K
2025 Q4
2 quarters
URG icon
681
Ur-Energy
URG
$367M
$960K 0.01%
706,190
– –
2026 Q1
1 quarter
SXC icon
682
SunCoke Energy
SXC
$854M
$941K 0.01%
116,940
-1,466
-1% -$11.3K
2025 Q2
4 quarters
GTM icon
683
ZoomInfo Technologies
GTM
$1.13B
$933K 0.01%
+318,405
New +$1.43M
2026 Q2
0 quarters
TLSI icon
684
TriSalus Life Sciences
TLSI
$255M
$910K 0.01%
200,060
– –
2026 Q1
1 quarter
FBNC icon
685
First Bancorp
FBNC
$2.47B
$895K 0.01%
14,000
– –
2022 Q4
14 quarters
USNA icon
686
Usana Health Sciences
USNA
$276M
$884K 0.01%
41,407
-4,004
-9% -$75.3K
2022 Q2
16 quarters
TMP icon
687
Tompkins Financial
TMP
$1.39B
$861K 0.01%
+9,107
New +$784K
2026 Q2
0 quarters
RAL icon
688
Ralliant Corp
RAL
$8B
$839K 0.01%
11,391
– –
2025 Q4
2 quarters
AER icon
689
AerCap
AER
$23B
$808K 0.01%
5,540
– –
2024 Q4
6 quarters
PTCT icon
690
PTC Therapeutics
PTCT
$5.25B
$777K 0.01%
9,523
-83,305
-90% -$6.02M
2025 Q2
4 quarters
BALL icon
691
Ball Corp
BALL
$15.7B
$734K 0.01%
11,770
+1,750
+17% +$103K
2025 Q1
5 quarters
BUR icon
692
Burford Capital
BUR
$764M
$718K 0.01%
175,000
– –
2023 Q4
10 quarters
ENSG icon
693
The Ensign Group
ENSG
$10.1B
$689K 0.01%
4,298
+1,847
+75% +$326K
2015 Q4
42 quarters
VNOM icon
694
Viper Energy
VNOM
$8.43B
$681K 0.01%
16,069
– –
2024 Q2
8 quarters
YSS icon
695
York Space Systems
YSS
$938M
$677K 0.01%
+27,510
New +$854K
2026 Q2
0 quarters
ASC icon
696
Ardmore Shipping
ASC
$810M
$643K 0.01%
45,870
-188,660
-80% -$3.2M
2013 Q3
51 quarters
TNET icon
697
TriNet
TNET
$2.98B
$623K 0.01%
12,585
+4,302
+52% +$184K
2025 Q3
3 quarters
TRDA icon
698
Entrada Therapeutics
TRDA
$214M
$610K ﹤0.01%
82,902
-37,943
-31% -$364K
2025 Q2
4 quarters
DSGX icon
699
Descartes Systems
DSGX
$7.16B
$583K ﹤0.01%
8,424
– –
2018 Q4
30 quarters
CBSH icon
700
Commerce Bancshares
CBSH
$7.83B
$580K ﹤0.01%
+10,049
New +$527K
2026 Q2
0 quarters

Similar funds

Royce & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
  • Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
  • Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
  • Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
  • Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
  • Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
  • Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.